Integrated Analysis of LncRNA-Mediated ceRNA Network in Calcific Aortic Valve Disease

Long Chen1, Ke Wei1, Jun Li1

  • 1State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Disease, China & Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.

Cells
|July 27, 2022
PubMed
Abstract

Insights

This study uncovers a novel long non-coding RNA (lncRNA)-microRNA-messenger RNA (mRNA) regulatory network in calcific aortic valve disease (CAVD). Key lncRNAs like H19 may offer new therapeutic targets for this condition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • RNA Biology

Background:

  • Calcific aortic valve disease (CAVD) presents significant morbidity and mortality, necessitating research into its underlying molecular mechanisms.
  • Long non-coding RNAs (lncRNAs) are implicated as competitive endogenous RNAs (ceRNAs) in cardiovascular diseases, but their specific role in CAVD remains largely unknown.

Purpose of the Study:

  • To investigate the role of lncRNA-mediated ceRNA networks in the pathogenesis of CAVD.
  • To identify potential molecular targets for therapeutic intervention in CAVD.

Main Methods:

  • Differential expression analysis of lncRNAs and mRNAs in CAVD tissues using RNA sequencing data.
  • Gene Ontology, KEGG pathway, and Gene Set Enrichment analyses to identify enriched biological pathways.
  • Prediction of microRNA targets and construction of a lncRNA-miRNA-mRNA ceRNA network using bioinformatics tools.
  • Validation of key lncRNAs via RT-qPCR in human aortic valve tissue samples.

Main Results:

  • Identification of 1739 differentially expressed mRNAs and 266 differentially expressed lncRNAs in CAVD.
  • Enrichment analysis revealed that these genes are predominantly involved in extracellular matrix (ECM)-reporter interaction pathways.
  • Construction of ceRNA networks associated with ECM pathways, highlighting upregulated lncRNAs (H19, SNHG3, ZNF436-AS1) in CAVD tissues.

Conclusions:

  • A novel lncRNA-miRNA-mRNA ceRNA network associated with ECM-reporter interaction pathways has been proposed.
  • This network potentially plays a crucial role in regulating the progression of calcific aortic valve disease.
  • Upregulated lncRNAs such as H19, SNHG3, and ZNF436-AS1 represent potential therapeutic targets for CAVD.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
2.2K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
112
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
31
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
35
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K